Larger hypothalamic volume in narcolepsy type 1.
MRI
T1
hypothalamus
narcolepsy
Journal
Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084
Informations de publication
Date de publication:
08 Nov 2023
08 Nov 2023
Historique:
received:
18
06
2022
revised:
18
05
2023
medline:
13
11
2023
pubmed:
18
7
2023
entrez:
18
7
2023
Statut:
ppublish
Résumé
Narcolepsy type 1 (NT1) is a neurological sleep disorder. Postmortem studies have shown 75%-90% loss of the 50 000-70 000 hypocretin-producing neurons and 64%-94% increase in the 64 000-120 000 histaminergic neurons and conflicting indications of gliosis in the hypothalamus of NT1 patients. The aim of this study was to compare MRI-based volumes of the hypothalamus in patients with NT1 and controls in vivo. We used a segmentation tool based on deep learning included in Freesurfer and computed the volume of the whole hypothalamus, left/right part of the hypothalamus, and 10 hypothalamic subregions. We included 54 patients with post-H1N1 NT1 (39 females, mean age 21.8 ± 11.0 years) and 114 controls (77 females, mean age 23.2 ± 9.0 years). Group differences were tested with general linear models using permutation testing in Permutation Analysis of Linear Models and evaluated after 10 000 permutations, yielding two-tailed P-values. Furthermore, a stepwise Bonferroni correction was performed after dividing hypothalamus into smaller regions. The analysis revealed larger volume for patients compared to controls for the whole hypothalamus (Cohen's d = 0.71, p = 0.0028) and for the left (d = 0.70, p = 0.0037) and right part of the hypothalamus (d = 0.65, p = 0.0075) and left (d = 0.72, p = 0.0036) and right tubular-inferior (d = 0.71, p = 0.0037) hypothalamic subregions. In conclusion, patients with post-H1N1 NT1 showed significantly larger hypothalamic volume than controls, in particular in the tubular-inferior subregions which could reflect several processes as previous studies have indicated neuroinflammation, gliosis, and changes in the numbers of different cell types.
Identifiants
pubmed: 37463428
pii: 7226142
doi: 10.1093/sleep/zsad173
pmc: PMC10636249
pii:
doi:
Substances chimiques
Orexins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Norwegian Ministry of Health and Care Services
ID : 2019032
Organisme : Research Council of Norway
ID : 276082
Organisme : European Union's Horizon 2020 Research and Innovation
ID : 802998
Organisme : South-Eastern Norway Regional Health Authority
ID : 2019101
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Sleep Research Society.
Références
Nat Rev Neurol. 2015 Jul;11(7):401-13
pubmed: 26100750
Neurology. 2009 Aug 18;73(7):511-7
pubmed: 19687452
Sleep. 2020 Mar 12;43(3):
pubmed: 31606740
Brain Pathol. 2003 Jul;13(3):340-51
pubmed: 12946023
Arch Neurol. 2002 Oct;59(10):1553-62
pubmed: 12374492
J Neuroimmunol. 2020 Mar 4;342:577210
pubmed: 32179327
Neurology. 2013 Apr 2;80(14):1315-21
pubmed: 23486871
Neurology. 2002 Jun 25;58(12):1852-5
pubmed: 12084891
Sleep. 2012 Mar 01;35(3):345-51
pubmed: 22379240
Proc Natl Acad Sci U S A. 2023 May 9;120(19):e2220911120
pubmed: 37126681
Brain. 2013 Aug;136(Pt 8):2486-96
pubmed: 23884811
Lancet Neurol. 2013 Nov;12(11):1068-75
pubmed: 24107292
Semin Immunopathol. 2022 Sep;44(5):611-623
pubmed: 35445831
Lancet Neurol. 2017 Mar;16(3):200-207
pubmed: 28129985
PLoS One. 2012;7(3):e33723
pubmed: 22470463
Brain Pathol. 2022 Mar;32(2):e13027
pubmed: 34672414
J Neurol. 2015 Dec;262(12):2635-42
pubmed: 26338813
Neuro Endocrinol Lett. 2006 Dec;27(6):769-72
pubmed: 17187022
Nat Med. 2000 Sep;6(9):991-7
pubmed: 10973318
J Sleep Res. 2016 Apr;25(2):181-9
pubmed: 26610427
Ann Neurol. 2013 Dec;74(6):794-804
pubmed: 24006291
Neuron. 2000 Sep;27(3):469-74
pubmed: 11055430
Neuroimage. 2014 May 15;92:381-97
pubmed: 24530839
Nat Med. 2002 Nov;8(11):1186-8
pubmed: 12411926
Sleep Med. 2015 Jan;16(1):39-44
pubmed: 25554349
Sleep Med. 2016 Mar;19:17-22
pubmed: 27198942
Neuroimage. 2015 Dec;123:253-68
pubmed: 26074200
Eur Neuropsychopharmacol. 2014 Mar;24(3):397-409
pubmed: 24345721
Br J Pharmacol. 2021 Feb;178(4):750-769
pubmed: 32744724
Sleep Med. 2014 Feb;15(2):262-5
pubmed: 24468101
Sleep. 2018 Oct 1;41(10):
pubmed: 30016530
Neuroradiology. 2022 Jul;64(7):1351-1357
pubmed: 35013760
Sleep. 2003 Feb 1;26(1):44-6
pubmed: 12627731
Nat Rev Neurol. 2019 Sep;15(9):519-539
pubmed: 31324898
Sleep Med Rev. 2018 Apr;38:177-186
pubmed: 28847694
Neuroscience. 1991;44(2):465-81
pubmed: 1719449
Neurology. 2006 Sep 26;67(6):1023-7
pubmed: 17000972
Sleep. 1999 Feb 1;22(1):77-87
pubmed: 9989368
Sleep Med. 2005 Nov;6(6):531-6
pubmed: 15994127
Nat Rev Dis Primers. 2017 Feb 09;3:16100
pubmed: 28179647
Handb Clin Neurol. 2019;160:393-403
pubmed: 31277864
Neurosci Res. 2019 May;142:16-29
pubmed: 29580887
Am J Psychiatry. 2010 Apr;167(4):397-408
pubmed: 20123910
Neuroimage. 2018 Apr 1;169:407-418
pubmed: 29278774
Neuroimage. 2020 Dec;223:117287
pubmed: 32853816
Acta Neurol Scand. 2009 Jan;119(1):61-7
pubmed: 18624787
Sleep. 2009 Aug;32(8):993-8
pubmed: 19725250
Sleep Med. 2013 Sep;14(9):867-71
pubmed: 23773727
Sleep. 2007 Aug;30(8):969-73
pubmed: 17702265
Neuroimage. 2013 Apr 1;69:1-10
pubmed: 23247186
Ann Neurol. 2013 Dec;74(6):786-93
pubmed: 23821583
Sleep. 2010 Feb;33(2):169-76
pubmed: 20175400
Sleep. 2019 Jul 8;42(7):
pubmed: 30923809
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4471-6
pubmed: 21368172
Korean J Radiol. 2009 Nov-Dec;10(6):552-8
pubmed: 19885310